Health
Study links milk-producing protein to aggressive breast cancer
Publish Date: Dec 30, 2012
Study links milk-producing protein to aggressive breast cancer
  • mail
  • img
newvision

HONG KONG - The discovery that a protein which triggers milk production in women may also be responsible for making breast cancers aggressive could open up new opportunities for treatment of the most common and deadliest form of cancer among women.

Found in all breast cells, the protein ELF5 tries to activate milk production even in breast cancer cells, which does not work and then makes the cancer more aggressive, according to scientists in Australia and Britain.

"The discovery opens up new avenues for therapy and for designing new markers that can predict response to therapy," said lead author Professor Chris Ormandy from the Garvan Institute of Medical Research in Sydney.

In 2008, Ormandy's work linked ELF5 to milk production.

The latest research by Ormandy and his team, published in the journal PLOS Biology on Friday, went a step further to find the link between ELF5 and breast cancer.

"Cancer cells can't respond properly (to ELF5), so they ... acquire some characteristics ... that make the disease more aggressive and more refractory (resistant) to treatment with existing therapies," Ormandy said by telephone.

Ormandy and his team grew human breast cancer tissues, genetically manipulated to contain high amounts of ELF5, in petri dishes and saw how the protein proliferated aggressively.

FINDINGS MAY HELP TARGETED THERAPY

Breast cancer is the most commonly diagnosed cancer and the top cause of cancer death among women, accounting for 23 percent of total cancer cases and 14 percent of cancer deaths in women.

To decide on treatment, doctors normally need to find out if the cancer has receptors for the hormones estrogen and progesterone, which, in the case of breast cancer patients, promote growth in their tumours.

Two-thirds of breast cancers are usually positive for estrogen receptors, which then require anti-hormonal therapies that lower estrogen levels in the patient or block estrogen from supporting the growth of the cancer.

For the remaining one-third of patients, their cancers do not have receptors, which means they won't benefit from hormonal therapies. Such patients are usually given other treatments, such as chemotherapy.

Ormandy's team found that cancers with these receptors had low levels of ELF5, while those without receptors had significantly higher levels of the protein.

"What we have shown in this paper is high ELF5 tumours are dependent on ELF5 for their proliferation and if we block ELF5 in high ELF5 tumours, we will block proliferation and that will treat the tumour," Ormandy said.

"If we can develop a drug that targets ELF5, it will be very useful for that group of women," he said.
 

The statements, comments, or opinions expressed through the use of New Vision Online are those of their respective authors, who are solely responsible for them, and do not necessarily represent the views held by the staff and management of New Vision Online.

New Vision Online reserves the right to moderate, publish or delete a post without warning or consultation with the author.Find out why we moderate comments. For any questions please contact digital@newvision.co.ug

  • mail
  • img
blog comments powered by Disqus
Also In This Section
Condoms
Ugandan MPs have been inundated with complaints that many condoms on sale are too small, warning the problem is a blow to the fight against AIDS....
New super-thin, skin-like condom being developed
The billionaire philanthropist says progress is being made on developing a "next-generation" ultra-thin, skin-like condom that could offer better sexual pleasure,...
Students push for Tobacco Control Bill passing
Students from five universities are petitioning parliament to pass the tobacco control bill, arguing that it has stayed too long on the shelf....
Mulago Hospital improves patients’ diet
Uganda’s national referral health facility Mulago Hospital has made adjustments to the meals it serves its in-patients, with a special diet introduced....
Obama: Ebola crisis
President Barack Obama issues a global call to action to fight the Ebola epidemic, warning the deadly outbreak was "spiraling out of control"....
200 Ugandan patients for sickle cell drug trial
At least 200 patients are to take part in a clinical trial for a more effective drug used to treat sickle cell anaemia....
Should bride price be made optional?
Yes
No
Can't Say
follow us
subscribe to our news letter